Long-term survival of breast cancer in Norway by age and clinical stage
Related Experiment Video
Updated: Oct 16, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Abstract:
In this paper 25-year survival for 8802 Norwegian women with breast cancer diagnosed during the period 1965 to 1974 is studied. It is suggested that some of the contradictory reports in the literature of the prognostic effect of age and clinical stage on long-term survival may be caused by interactions and time varying effects of covariates. When using a linear non-parametric regression model that allows the covariates to vary over time, age and clinical stage are found to be significant long-term prognostic factors. A significantly higher excess mortality for women less than 35 years at diagnosis disappeared after 8 years, while for those above 55 years an important effect of age on the long-term survival, especially for those with regional cancer, was seen. The effect of clinical stage on survival varies strongly over time, and was significant between 15 and 20 years.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Longitudinal Research
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis